发明名称 |
Hexenone compounds and medical use thereof |
摘要 |
The present invention relates to a compound of Formula I, or an isomer, pharmaceutically acceptable salt and solvate thereof; to a composition comprising a compound of Formula I, or an isomer, pharmaceutically acceptable salt and solvate thereof, and a pharmaceutically acceptable carrier, excipient or diluent; and also to use of a compound of Formula I, or an isomer, pharmaceutically acceptable salt and solvate thereof for combating apoptosis, or preventing or treating a disease or disorder associated with apoptosis; and especially use for protecting cardiomyocyte, or preventing or treating a disease or disorder associated with cardiomyocyte apoptosis.; |
申请公布号 |
US8884007(B2) |
申请公布日期 |
2014.11.11 |
申请号 |
US201113696697 |
申请日期 |
2011.05.16 |
申请人 |
Institute of Pharmacology and Toxicology Medical Sciences P.L.A. China |
发明人 |
Li Song;Zhong Wu;Liu Juan;Wang Lili;He Kunlun;Long Long;Xiao Junhai;Zheng Zhibing;Li Wei;Li Xin;Hu Guoliang |
分类号 |
C07D295/215;C07D295/194 |
主分类号 |
C07D295/215 |
代理机构 |
Roberts Mlotkowski Safran & Cole, P.C. |
代理人 |
Roberts Mlotkowski Safran & Cole, P.C. |
主权项 |
1. A compound of Formula I, or pharmaceutically acceptable salt or solvate thereof, wherein: A represents ═S, —SR4 or ═O; X represents F, Cl, Br or I; R1 represents phenyl; R2, and R3 are attached together to form morpholine; and R4 represents C1-C6 alkyl. |
地址 |
Beijing CN |